92 related articles for article (PubMed ID: 10476345)
1. [Adrenocortical tumors: mitotic index and nuclear size as criteria for differential diagnosis and prognosis].
Poliakova GA; Kazantseva IA; Kalinin AP; Perov AI; Bokova EV
Arkh Patol; 1999; 61(3):30-4. PubMed ID: 10476345
[TBL] [Abstract][Full Text] [Related]
2. Indicators of malignancy of canine adrenocortical tumors: histopathology and proliferation index.
Labelle P; Kyles AE; Farver TB; De Cock HE
Vet Pathol; 2004 Sep; 41(5):490-7. PubMed ID: 15347821
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.
Volante M; Bollito E; Sperone P; Tavaglione V; Daffara F; Porpiglia F; Terzolo M; Berruti A; Papotti M
Histopathology; 2009 Nov; 55(5):535-43. PubMed ID: 19912359
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.
Stojadinovic A; Brennan MF; Hoos A; Omeroglu A; Leung DH; Dudas ME; Nissan A; Cordon-Cardo C; Ghossein RA
Mod Pathol; 2003 Aug; 16(8):742-51. PubMed ID: 12920217
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas.
van't Sant HP; Bouvy ND; Kazemier G; Bonjer HJ; Hop WC; Feelders RA; de Herder WW; de Krijger RR
Histopathology; 2007 Aug; 51(2):239-45. PubMed ID: 17593212
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
8. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas.
Song SY; Park S; Kim SR; Suh YL
Pathol Int; 2004 Aug; 54(8):603-10. PubMed ID: 15260851
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical neoplasms in young children: age as a prognostic factor.
Ahmed AA
Ann Clin Lab Sci; 2009; 39(3):277-82. PubMed ID: 19667412
[TBL] [Abstract][Full Text] [Related]
10. A small adrenocortical carcinoma with aggressive behavior. An evaluation of criteria for malignancy.
Gandour MJ; Grizzle WE
Arch Pathol Lab Med; 1986 Nov; 110(11):1076-9. PubMed ID: 3778125
[TBL] [Abstract][Full Text] [Related]
11. Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma.
Haak HR; Cornelisse CJ; Hermans J; Cobben L; Fleuren GJ
Br J Cancer; 1993 Jul; 68(1):151-5. PubMed ID: 8318407
[TBL] [Abstract][Full Text] [Related]
12. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
Blanes A; Diaz-Cano SJ
Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
[TBL] [Abstract][Full Text] [Related]
13. Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.
Blanes A; Diaz-Cano SJ
Am J Clin Pathol; 2007 Mar; 127(3):398-408. PubMed ID: 17276949
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiology, diagnosis and prognosis of adrenocortical tumors revisited by transcriptome analyses.
Assié G; Guillaud-Bataille M; Ragazzon B; Bertagna X; Bertherat J; Clauser E
Trends Endocrinol Metab; 2010 May; 21(5):325-34. PubMed ID: 20097573
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
Takehara K; Sakai H; Shono T; Irie J; Kanetake H
Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
[TBL] [Abstract][Full Text] [Related]
16. [Parathyroid adenoma and carcinoma. A comparative morphologic study].
Morelli A; Vergani P; Ronchetti R; Argeri CB; Elsner B
Medicina (B Aires); 1991; 51(6):507-10. PubMed ID: 7476102
[TBL] [Abstract][Full Text] [Related]
17. [Ultrastructural criteria of clinical prognosis in hormonally non-active adrenocortical tumors].
Raĭkhlin NT; Baronin AA; Smirnova EA; Probatova NA; Bronsteĭn MI; Bukaeva IA
Vopr Onkol; 2003; 49(1):44-50. PubMed ID: 12715369
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
19. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
Lau SK; Weiss LM
Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.
Sasano H; Suzuki T; Moriya T
Endocr Pathol; 2006; 17(4):345-54. PubMed ID: 17525483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
